CLOUDR (09955) Signs Service Cooperation Agreement with JD HEALTH (06618) to Expand Online Sales and Service Channels for Remifemin® and Other P2M Pipeline Products

Stock News

Yesterday

CLOUDR (09955) announced that the company has recently entered into a service cooperation agreement with JD HEALTH (06618). The collaboration aims to expand online sales and service channels for Remifemin® and other P2M pipeline products, providing patients with more convenient medication purchasing experiences and professional full-cycle health management services. As China's largest pharmaceutical e-commerce platform, JD HEALTH boasts a vast user base and extensive platform resources. Meanwhile, CLOUDR, a leading chronic disease management platform in China, possesses a unique product pipeline and expertise in patient-doctor management. This partnership represents a powerful alliance that will efficiently promote high-quality and cost-effective pharmaceutical products.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1177484884"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1177484884\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1177484884?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-13 12:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177484884","market":"fut","top_or_hot":-1,"title":"CLOUDR (09955) Signs Service Cooperation Agreement with JD HEALTH (06618) to Expand Online Sales and Service Channels for Remifemin® and Other P2M Pipeline Products","media":"Stock News","content":"<p>CLOUDR (09955) announced that the company has recently entered into a service cooperation agreement with JD HEALTH (06618). The collaboration aims to expand online sales and service channels for Remifemin® and other P2M pipeline products, providing patients with more convenient medication purchasing experiences and professional full-cycle health management services. As China's largest pharmaceutical e-commerce platform, JD HEALTH boasts a vast user base and extensive platform resources. Meanwhile, CLOUDR, a leading chronic disease management platform in China, possesses a unique product pipeline and expertise in patient-doctor management. This partnership represents a powerful alliance that will efficiently promote high-quality and cost-effective pharmaceutical products.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CLOUDR (09955) Signs Service Cooperation Agreement with JD HEALTH (06618) to Expand Online Sales and Service Channels for Remifemin® and Other P2M Pipeline Products</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCLOUDR (09955) Signs Service Cooperation Agreement with JD HEALTH (06618) to Expand Online Sales and Service Channels for Remifemin® and Other P2M Pipeline Products\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-13 12:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CLOUDR (09955) announced that the company has recently entered into a service cooperation agreement with JD HEALTH (06618). The collaboration aims to expand online sales and service channels for Remifemin® and other P2M pipeline products, providing patients with more convenient medication purchasing experiences and professional full-cycle health management services. As China's largest pharmaceutical e-commerce platform, JD HEALTH boasts a vast user base and extensive platform resources. Meanwhile, CLOUDR, a leading chronic disease management platform in China, possesses a unique product pipeline and expertise in patient-doctor management. This partnership represents a powerful alliance that will efficiently promote high-quality and cost-effective pharmaceutical products.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"","article_id":"1177484884","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177484884","pubTimestamp":1763007490,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"CLOUDR (09955) announced that the company has recently entered into a service cooperation agreement with JD HEALTH (06618). The collaboration aims to expand online sales and service channels for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"86618":"京东健康-R","BK1583":"高瓴概念","BK1617":"AI医疗","09955":"智云健康","BK1197":"保健护理产品经销商","BK1571":"互联网医疗","SGXZ86797644.SGD":"MAYBANK ASIAN GROWTH AND INCOME-I \"A\" (SGDHDG) INC","BK1589":"北水核心资产","LU0051755006.USD":"摩根大通中国A (dist)","BK1515":"抗疫概念","SGXZ62798434.SGD":"MAYBANK ASIAN GROWTH AND INCOME-I \"A\" (SGDHDG) ACC","BK1615":"港股-互联网","BK1591":"就地过年概念","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","BK1142":"互联网与直销零售","06618":"京东健康","BK1247":"药品零售"},"translate_title":"CLOUDR(09955)与京东健康(06618)签署服务合作协议拓展瑞米芬线上销售及服务渠道®和其他P2M管道产品","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"86618":1,"06618":1,"09955":1},"content_text":"CLOUDR (09955) announced that the company has recently entered into a service cooperation agreement with JD HEALTH (06618). The collaboration aims to expand online sales and service channels for Remifemin® and other P2M pipeline products, providing patients with more convenient medication purchasing experiences and professional full-cycle health management services. As China's largest pharmaceutical e-commerce platform, JD HEALTH boasts a vast user base and extensive platform resources. Meanwhile, CLOUDR, a leading chronic disease management platform in China, possesses a unique product pipeline and expertise in patient-doctor management. This partnership represents a powerful alliance that will efficiently promote high-quality and cost-effective pharmaceutical products.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}